Exhibit 107
Calculation of Filing Fee Tables
S-1
(Form Type)
QUOIN PHARMACEUTICALS LTD.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount to be Registered | Proposed Maximum Offering Price Per Unit | Proposed Maximum Aggregate Offering Price(1)(2) | Fee Rate | Amount of Registration Fee | ||||||||||
| Equity | Ordinary shares, no par value per share (“Ordinary Shares”), represented by American Depositary Shares (“ADSs”) (5) | Rule 457(o) | — | — | $ | 15,000,000(3) | $ | 0.00015310 | $ | 2,296.50 | |||||||
| Equity | Pre-Funded Warrants to purchase Ordinary Shares represented by ADSs | Rule 457(g) | — | — | $ | (4) | — | ||||||||||
| Equity | Ordinary Shares represented by ADSs issuable upon exercise of the Pre-Funded Warrant | Rule 457(o) | — | — | $ | (3) | — | ||||||||||
| Equity | Series F Warrants to purchase Ordinary Shares represented by ADSs | Rule 457(g) | — | — | $ | (4) | — | ||||||||||
| Equity | Ordinary Shares represented by ADSs issuable upon exercise of the Series F Warrant | Rule 457(o) | — | — | $ | 15,000,000 | $ | 0.00015310 | $ | 2,296.50 | |||||||
| Equity | Series G Warrants to purchase Ordinary Shares represented by ADSs | Rule 457(g) | — | — | $ | (4) | — | ||||||||||
| Equity | Ordinary Shares represented by ADSs issuable upon exercise of the Series G Warrant | Rule 457(o) | — | — | $ | 15,000,000 | $ | 0.00015310 | $ | 2,296.50 | |||||||
| Total Offering Amounts | $ | 45,000,000 | $ | 6,889.50 | |||||||||||||
| Total Fees Previously Paid | — | ||||||||||||||||
| Total Fee Offsets | |||||||||||||||||
| Net Fee Due | $ | 6,889.50 | |||||||||||||||
| (1) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). |
| (2) | Pursuant to Rule 416(a) under the Securities Act, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
| (3) | The proposed maximum aggregate offering price of Ordinary Shares represented by ADSs proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants sold in the offering, and, as such, the proposed maximum aggregate offering price of the Ordinary Shares represented by ADSs and Pre-Funded Warrants (including the Ordinary Shares represented by ADSs issuable upon exercise of the Pre-Funded Warrants), if any, is $15,000,000. |
| (4) | Pursuant to Rule 457(g) of the Securities Act, no separate registration fee is required for the Warrants because the Warrants are being registered in the same registration statement as the Ordinary Shares represented by ADSs issuable upon exercise of the Warrants. |
| (5) | American Depositary Shares (“ADSs”) issuable upon deposit of ordinary shares registered hereby have been registered under a separate registration statement on Form F-6 (Registration No. 333-212698) filed with the Securities and Exchange Commission. Each ADS represents one Ordinary Share. |
